1.Detection and clinical significance of serum cholinesterase, lactic dehydrogenate and β2-microglobulin in non-Hodgkin lymphoma patients
Journal of Leukemia & Lymphoma 2011;20(5):289-291
Objective To study the relationship between the serum level of cholinesterase (CHE) and patient's clinical characteristics and serum levels of lactic dehydrogenate(LDH) and β2-microglobulin (β2-MG) in non-Hodgkin lymphoma(NHL) patients. Methods The levels of CHE, LDH, β2-MG were detected with rate method and immunoassay respectively in 74 patients, and then these patients were divided into low (38 patients) and high level groups (36 patients) according to the serum CHE levels, compared with clinical characteristics and serum levels of LDH and β2-MG between the two groups. Results There were a significant difference in serum levels of CHE, LDH, β2-MG between the low and the high CHE level group [(3714.2 ±1207.1) U/L, (435.7±364.4) U/L, (4.3±2.9) mg/L; (7898.2± 1550.5) U/L, (247.4±134.8) U/L, (2.7±1.2) mg/L, respectively] (t =10.510, P =0.000; t =2.969, P =0.005; t =3.043, P =0.004, respectively). There were no statically significance in age, pathology type, leukocyte and platelet between the low and high serum CHE level groups (t =0.166, P =0.868; x2 =0.751, P=0.386; t =1.626, P=0.111; t =1.987, P=0.056, respectively). Patients with low CHE level group were mostly in Ann Arbor Ⅲ-Ⅳ period (x2 =9.394, P =0.024) and mostly male patients compared with the high CHE level group patients (x2 =5.432, P =0.020). The quantity of hemoglobin in the low CHE level group(97.6±25.8) g/L were lower than that of the high level group (113.4±15.2) g/L (t = 3.230, P =0.002). Conclusion The low CHE level was not correlated with age, pathology type, leukocyte and platelet, but was related with male, Ann Arbor Ⅲ-Ⅳ period, anemia, and higher expression of LDH, β2-MG.
3.Analysis of the Regulatory Policies Progress of Biosimilars in Foreign Countries and Its Enlightenment to China
China Pharmacy 2016;27(1):8-11
OBJECTIVE:To explore the development status of regulatory policies of biosimilars in foreign countries,and to provide reference for perfecting biosimilars regulatory policies in China. METHODS:Comparative analysis was conducted,con-cerning biosimilar regulations and directories which had been issued by WHO,EMA and FDA,in aspects of biosimilars definition, the choice of reference drug,quality studies,non-clinical studies,clinical studies. RESULTS & CONCLUSIONS:Three common points found in foreign regulatory policies were that:firstly,discrepancies were allowed between biosimilars and reference drugs;secondly,the comparison was itemized between biosimilars and reference drugs on safety and effectiveness,in order to guarantee the reliability of quality research;thirdly,clinical and non-clinical studies were reduced with a premise that similarity is confirmed. Given China's current situation,several parts of policies should be improved,including stressing pertinence of reference drug selec-tion,refining preclinical and clinical study directories and establishing supporting system after listing.
4.Trends in detection methods of ricin
Bulletin of The Academy of Military Medical Sciences 2009;33(6):573-576
Ricin is a plant-derived ribosome-inhibitor which can be easily purified in large quantities from castor beans. It is a potent irreversible inhibitor of protein synthesis. The mode of intoxication could be inhalation, ingestion, intravenous injection.Ricin has been classified as a schedule 1 threat agent by the Chemical Weapons Convention.A fast and sensitive method for the detection of this threat agent is an important tool for preventing or dealing with the consequences of intoxication. An ideal method should be highly sensitve, highly selective, and well capable of identifying ricin in a short assay time. Several methods have been established for ricin detection. This review summaries the development of detection methods for ricin in recent years.
5.Application of multidisciplinary integrated management model in medical management of elderly patients
Nianhuan CHANG ; Xia LI ; Qingmei WEI
Chinese Journal of Primary Medicine and Pharmacy 2017;24(13):1981-1984
Objective To investigate the clinical efficacy of multidisciplinary integrated treatment and management model in the medical management of elderly patients.Methods 226 elderly patients treated in our hospital from October 2014 to December 2015 were randomly divided into observation group and control group,113 cases in each group.Patients in the control group were treated with traditional medical management model,while patients in the observation group were treated with multidisciplinary integrated treatment and management model.The therapeutic effect,hospital stay,incidence of complications,treatment satisfaction,MMSE score,FCA score and Tinetti score between the two groups were compared.Results The total effective rate (95.58%) in the observation group was significantly higher than that in the control group (79.65%) (χ2=13.21,P=0.000).The mortality rate in the observation group (1.77%) was significantly lower than 7.96% in the control group (χ2=4.68,P=0.004).The satisfaction rate of the observation group (92.04%) was significantly higher than 77.88% of the control group (χ2=8.86,P=0.003).The MMSE score[(25.17±4.43)points],FCA score[(77.35±8.35)points]and Tinetti score[(26.45±4.25)points]of the observation group were significantly higher than those in the control group[(20.13±3.07) points,(65.32±8.88) points and (21.03±3.30) points,t=-2.93,-3.11,-3.18;P=0.025,0.014,0.006].Conclusion Multidisciplinary integrated treatment management model can significantly increase the therapeutic effect,shorter hospital stay,reduce the incidence of complications,improve patients' satisfaction,and improve the quality of life,so it is a new type of efficient and rational therapeutic management model and worthy of clinical promoting.
6.Role of free hemoglobin and its receptor CD163 in the rat atherosclerosis formation
Haizhou LI ; Hao XIA ; Wei WANG
Chinese Journal of Pathophysiology 1999;0(09):-
AIM:To investigate the influence of free hemoglobin on the initiation and progression of atherosclerosis and the role of CD163 in this process.METHODS:Thirty male SD rats were randomly divided into three groups:control group(group C),atherosclerosis group(group A),atherosclerosis and hemolysis group(group P).The hemolysis and atherosclerosis animal model was established.The free hemoglobin(FHb)and MDA levels in plasma,(RAAPIs)and intima area/midmembrane area(I/M)of each group were measured.The expressions of CD163 and heme oxygenase-1(HO-1)in atherosclerosis plaques in group A and P were detected and measured by means of immunohistochemistry and Western blotting.RESULTS:Compared with group C,the FHb,MDA,CD163 and HO-1 in group A and group P increased significantly(P0.05).The FHb level in plasma and the expressions of CD163 and HO-1 in atherosclerotic plaques correlated with each other(r=0.526,r=0.498,r=0.653;P
7.Hemorrheological changes after tourniquet deflation in rabbits
Wei LI ; Haichen CHU ; Renyun XIA
Chinese Journal of Anesthesiology 1995;0(02):-
Objective To evaluate the hemorrheological changes after tourniquet deflation.Methods Twenty rabbits were subjected to lower extremity tourniquet inflation for 3 h. Venous blood samples were taken before tourniquet inflation and 2min after tourniquet deflation for measurement of hemorrheological parameters: low-shear viscosity and high-shear viscosity of whole blood; plasma high-shear viscosity , hematocrit; fibrinogen; aggreability,deformability and stiffness of erythrocyte; and blood sedimentation K value. The levels of parameters before tourniquet inflation served as baseline values. The gastrocnemius muscle samples were taken before tourniquet inflation and 5 min after torrniquet deflaion for observation of ultrastructure of small blood vessel.Results Compared with the baseline values, the levels of low- and high- shear viscosities of whole blood, plasma viscosity, fibrinogen, blood sedimentation K value, and aggreability and stiffness of erythrocyte increased significantly (P
8.The efficacy and safety of noninvasive ventilation in chronic obstructive pulmonary disease complicated with chronic respiratory failure
Xia LI ; Qingmei WEI ; Nianhuan CHANG
Chinese Journal of Primary Medicine and Pharmacy 2015;(19):2956-2958
Objective To investigate the treatment of noninvasive ventilator in chronic obstructive pulmonary disease merge chronic type Ⅱ respiratory failure and to analysis its clinical efficacy and safety.Methods According to the random number table,115 cases were randomly divided into two groups,the observation group (n =59)and the control group(n =56).The control group received conventional symptomatic treatment,while the observation group therapy was combined with non -invasive ventilation in the basis of the control group.The changes of HR,RR, PaCO2 ,PaO2 ,Forced expiratory volume in one second 1 (FEV1 ),Forced expiratory volume in one second 1 (Forced expiratory volume in one second 1,FEV1 /FVC)were compared between the two groups before and after treatment 48h.Results Before treatment,there were no significant differences in HR,PaCO2 ,RR,FEV1 ,PaO2 ,FEV1 /FVC (P >0.05).After the treatment,in the control group,HR,RR,PaCO2 ,PaO2 ,FEV1 and FEV1 /FVC were respectively (90.16 ±4.15)beats/min,(23.17 ±1.63)beats/min,(59.68 ±5.85)mmHg,(69.16 ±5.26)mmHg,(2.65 ± 0.25)L and(65.47 ±1.97)%.In the observation group,HR,RR,PaCO2 ,PaO2 ,FEV1 and FEV1 /FVC were respectively (82.93 ±3.76)beats/min,(19.02 ±1.57)beats/min,(50.82 ±6.53)mmHg,(78.06 ±5.48)mmHg,(2.96 ± 0.31)L and (72.38 ±2.15)%.The difference was statistically significant(t =9.800,13.907,7.649,8.877,5.917, 17.942,all P <0.05).No adverse reactions occurred during the treatment.Conclusion The clinical efficacy of non-invasive ventilator in the treatment of COPD associated with chronic type Ⅱ respiratory failure is significant,safe and reliable,which has important research value,and is worthy of further application.
9.Design and Practice of the New Mode of Mobile Medical Service in Hospitals
Journal of Medical Informatics 2015;(9):23-26
〔Abstract〕 In the paper , the status quo of mobile medical service is analyzed , proving a new mode of mobile medical service for pa-tients.The suggested functions like self -service information query and medical service guiding as well as solutions to the relevant system structure and information security are elaborated in detail .In addition, the feasibility of construction of applications for mobile medical di-agnosis and treatment is also discussed .
10.Chronic lymphocytic leukemia.
Yi XIA ; Wei XU ; Jian-yong LI
Chinese Journal of Hematology 2013;34(2):182-183